Transaction overview
Stefan A. Dyckerhoff, who serves on the board of Astera Labs, Inc. (NASDAQ: ALAB), completed planned sales of company stock on April 17 and April 20, 2026. The two sets of transactions together covered 24,998 shares of common stock and generated total proceeds of $4,376,257. The per-share prices for the trades ranged from $175.00 to $175.51. Mr. Dyckerhoff executed these sales pursuant to a Rule 10b5-1 trading plan he adopted on December 1, 2025.
Details by date and vehicle
On April 17, Mr. Dyckerhoff sold 11,599 shares. That day's activity comprised three components: 3,253 shares sold directly by Mr. Dyckerhoff, 7,733 shares sold indirectly through a trust, and 613 shares sold indirectly via a limited partnership. The prices for the April 17 trades ranged from $175.00 to $175.01 per share.
Following the April 17 transactions, his holdings were recorded as 70,901 shares held directly, 345,331 shares held indirectly through a trust, and 7,323 shares held indirectly through a limited partnership.
On April 20, Mr. Dyckerhoff sold an additional 13,399 shares. That day's breakdown included 3,757 shares sold directly, 8,933 shares sold indirectly through a trust, and 709 shares sold indirectly through a limited partnership. The prices for the April 20 trades ranged from $175.02 to $175.51 per share.
After closing the April 20 transactions, Mr. Dyckerhoff's reported holdings stood at 67,144 shares directly, 336,398 shares indirectly through a trust, and 6,614 shares indirectly through a limited partnership.
Market context and valuation
The insider sales occurred while ALAB shares have advanced 223% over the past year. At the time of the reporting, the stock was trading at $192.02 and the company carried a market capitalization of $32.75 billion. Analysis from InvestingPro indicated the stock appears overvalued relative to its Fair Value and placed the company on its Most Overvalued list.
Investors tracking the company also face a near-term corporate event: Astera Labs is scheduled to report quarterly results in 14 days, with the earnings release set for May 5, 2026.
Recent financial results and analyst commentary
Astera Labs reported strong fourth-quarter 2025 results, delivering earnings per share of $0.58 versus analyst expectations of $0.51. Quarterly revenue reached $270.6 million, a year-over-year increase of 92%.
On the analyst front, RBC Capital raised its price target for Astera Labs stock to $250 while keeping an Outperform rating. RBC cited expected growth tied to Trainium3-related Scorpio-X switch revenue, which is projected to begin in the third quarter of 2026.
Separately, UBS initiated coverage of Astera Labs with a Neutral rating and set a price target of $180. Analyst Natalia Winkler remarked that the company has become a credible AI networking supplier over the past five years and has broadened its customer base beyond its initial anchor customer, Amazon Web Services, expanding adoption among additional hyperscalers.
Where to find more company research
For investors seeking further valuation context and financial detail, a comprehensive Pro Research Report is available for this company and for more than 1,400 other U.S. equities.
Note on presentation
This article presents transaction-level details reported for a director of Astera Labs, company financial results released for the fourth quarter of 2025, and analyst ratings and price targets as stated above. The timeline and numbers included reflect the information provided relating to the insider sales, the company's recent operating results, and analyst commentary.